Hiroki Izumi

12PUBLICATIONS
171CO-AUTHORS
Molecular targetsAutoimmunityPredictive and prognostic markersLiquid biopsiesCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Aug 10, 2026
Rilvegostomig for Metastatic Non-Small-Cell Lung Cancer: A First-In-Human Phase I/II Clinical Study.

|Feb 04, 2026
Concurrent Pituitary and Thyroid Immune-Related Adverse Events after Immune Checkpoint Inhibitors Associated with HLA-DR15-Related Haplotypes.

Tomoko Kobayashi, Shintaro Iwama, Eri Sugiyama

|Sep 25, 2025
Efficacy and Safety of Nivolumab Monotherapy in Patients with High PD-1-Positive CD8/Treg Ratio in Advanced NSCLC and Gastric Cancer: A Phase II, Multicenter Study.

Kohei Shitara, Motohiro Tamiya, Kyoichi Okishio

|Oct 28, 2024
Oncogenic HRAS Induces Metformin Resistance in Head and Neck Cancer by Promoting Glycolytic Metabolism.

Xingyu Wu, Sendi Rafael Adame-Garcia, Keiichi Koshizuka

|Aug 29, 2024
Sustained Clinical Benefit and Intracranial Activity of Tarlatamab in Previously Treated Small Cell Lung Cancer: DeLLphi-300 Trial Update.

Afshin Dowlati, Horst-Dieter Hummel, Stephane Champiat

|Jul 02, 2024
A Kinome-Wide Synthetic Lethal CRISPR/Cas9 Screen Reveals That mTOR Inhibition Prevents Adaptive Resistance to CDK4/CDK6 Blockade in HNSCC.

Yusuke Goto, Keiichi Koshizuka, Toshinori Ando

Pageof 2

Frequent Collaborators

3 joint publications

Tatsuya Yoshida

3 joint publications

Enriqueta Felip

3 joint publications

Luis Paz-Ares

3 joint publications

Koichi Goto